China Medical University Hospital (CMUH) has developed ‘BrainHealth’, an AI dementia diagnosis system that can assess the severity in just one minute.

The AI model has an area under the curve (AUC) of 87% and a sensitivity of 91.7%.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

An 81-year-old patient experienced increasing memory and communication difficulties. At CMUH, he underwent traditional evaluations, including blood tests, mental capacity assessments, and an MRI. The results showed brain atrophy and a lower-than-average Mini Mental State Examination (MMSE) score for his age.

These data from the tests, along with additional MRI findings, were input into the ‘BrainHealth’ system.

The AI predicted that the patient’s brain was five years older than his actual age and indicated early-stage dementia, aligning with the conventional examination results.

The AI Brain Age Prediction System, a component of ‘BrainHealth’, uses MRI data from thousands of healthy individuals and dementia patients to create a normal distribution curve of brain regions.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Furthermore, BrainHealth’s hereditary neurological disorder testing system detects Alzheimer’s disease by using an AI model that compares brain waves and genetic characteristics against data from elderly individuals with and without neurological disorders.

The BrainHealth AI system also features a Neural Gene Discrimination System to allow complex assessments of dementia severity.

Recently, CMUH developed a new home-based system, Intelligent Detection of Respiratory Events through Automated Monitoring (iDREAM), for detecting sleep apnoea.

Featuring Quanta’s QOCA Portable ECG Monitoring Device, the iDREAM system demonstrated an accuracy rate of 95.8% for identifying severe obstructive sleep apnoea syndrome (OSAS).

Using AI, the device can accurately detect severe obstructive OSAS during sleep sessions at home.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact